Downloads: 4 | Views: 238 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Research Paper | Obstetrics and Gynecology | India | Volume 13 Issue 10, October 2024 | Popularity: 5.1 / 10
Efficacy and Safety of Oral Mifepristone as a Cervical Ripening Agent for Labor Induction in Low-Risk Full-Term Live Pregnancies Beyond 40 Weeks of Gestation: A Randomized Controlled Study
Dr. Nikita Yadav, Dr. Hanslata Gehlot, Dr. Rakesh Bagri
Abstract: This study evaluates the efficacy and safety of oral mifepristone as a cervical ripening agent for inducing labor in low-risk, full-term live pregnancies beyond 40 weeks of gestation. In this randomized controlled trial, 100 pregnant women were equally divided into two groups: the study group receiving 200 mg oral mifepristone and the control group undergoing expectant management. The primary outcomes measured were improvement in Bishop's score within 24-48 hours and the onset of labor within 72 hours. Secondary outcomes included allocation-to-delivery interval, the requirement for additional labor inducers, maternal and neonatal outcomes, and mode of delivery. Results showed significant improvements in cervical ripening, reduced need for additional labor inducers, and a shorter induction-to-delivery interval in the mifepristone group. Mifepristone demonstrated excellent safety and efficacy in inducing labor with minimal side effects, suggesting its potential role as a primary agent in labor induction protocols.
Keywords: Mifepristone, Cervical ripening, Term pregnancy, Labor induction, Pregnancy outcomes
Edition: Volume 13 Issue 10, October 2024
Pages: 965 - 968
DOI: https://www.doi.org/10.21275/SR241010212021
Please Disable the Pop-Up Blocker of Web Browser
Verification Code will appear in 2 Seconds ... Wait